Global Point of Care Molecular Diagnostics
Market Report
2025
Point-of-Care Molecular Diagnostics Market size is expected to grow from USD 7.70 billion in 2022 to USD 9.90 billion by 2030, at a CAGR of 3.2% during the forecast period.2023 to 2030
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Point of Care Molecular Diagnostics Market Report 2025.
The Global Point-of-Care Molecular Diagnostics Market size is expected to grow from USD 7.70 billion in 2022 to USD 9.90 billion by 2030, at a CAGR of 3.2% during the forecast period.2023 to 2030
2021 | 2025 | 2033 | CAGR | |
---|---|---|---|---|
Global Point of Care Molecular Diagnostics Market Sales Revenue | 121212 | 121212 | 121212 | 3.2% |
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Market Split by By Product |
|
Market Split by By Technology |
|
Market Split by By Application |
|
Market Split by By Test Location |
|
Market Split by By End-Use |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Report scope is customizable as we have a huge database of Point of Care Molecular Diagnostics industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Point of Care Molecular Diagnostics Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Point of care molecular diagnostics (POC-MDx) is a type of medical testing that allows healthcare providers to rapidly detect and diagnose a wide range of diseases and conditions at the patient's bedside or in the clinic. Point of care molecular diagnostics use molecular biology techniques, such as polymerase chain reaction (PCR) or nucleic acid amplification tests (NAATs), to identify the presence of specific genetic or protein markers that are associated with a particular disease or condition.
The rising prevalence of chronic and infectious diseases such as COVID-19, HIV, HBC, and HCV is driving the growth of the market. Point-of-Care Molecular Diagnostics tests enable early detection and monitoring of these diseases, leading to better patient outcomes and reduced healthcare costs.
The increasing demand for rapid and accurate diagnosis drives innovation in the field. This is crucial in managing infectious diseases and improving patient outcomes. With the rise of infectious diseases such as COVID-19, the demand for rapid and accurate diagnostic tests has increased significantly. This factor supports the growth of the Point-of-Care Molecular Diagnostics Market.
Moreover, increasing advances in technology, such as miniaturization of diagnostic devices, improved assay sensitivity and specificity, and the integration of electronic medical records, have made Point-of-Care Molecular Diagnostics tests more accessible and user-friendly. This is projected to increase the demand for Point-of-Care Molecular Diagnostics.
We have various report editions of Point of Care Molecular Diagnostics Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.
The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.
Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.
Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.
Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.
In March 2020, Abbott announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes. The test will run on the company's ID NOW platform, providing rapid results in a wide range of healthcare settings such as physicians' offices, urgent care clinics and hospital emergency departments.
Top Companies Market Share in Point of Care Molecular Diagnostics Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
North America accounted for the major market share in the year 2022 owing to growing geriatric population, increasing healthcare expenditure and increasing demand for new technologies. This is driving the Point-of-Care Molecular Diagnostics market in this region. Moreover, increasing research and development spending and rising government support is projected to increase the growth of the Point-of-Care Molecular Diagnostics Market.
The current report Scope analyzes Point of Care Molecular Diagnostics Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Global Point of Care Molecular Diagnostics Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Point of Care Molecular Diagnostics Industry growth. Point of Care Molecular Diagnostics market has been segmented with the help of its By Product, By Technology By Application, and others. Point of Care Molecular Diagnostics market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Assays and kits segment held the major market share of Point-of-Care Molecular Diagnostics Market owing to increasing use of this products in the laboratory to research drugs and increasing need for quick and accurate testing is supporting the market growth.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Point of Care Molecular Diagnostics Industry. Request a Free Sample PDF!
Based on Technology, PCR based technology segment held the major share of the Point-of-Care Molecular Diagnostics market in the year 2022 owing to increasing demand for RT-PCR tests for infectious diseases.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Based on application, infectious diseases segment held the largest market share owing to growing prevalence of infectious diseases and demand for Point-of-Care Molecular Diagnostics for the detection of diseases such as COVID-19 which requires rapid and accurate diagnosis to manage infectious diseases and improving patient outcomes.
Based on Test Location, POC test location segment held a significant share of the market. This is attributed to the growing adoption of POC tests across hospitals, clinics, and ambulatory centres.
Based on End-Use, the Decentralized Labs segment dominated the market owing to Point-of-Care Molecular Diagnostics test ability to provide rapid and accurate diagnosis and availability of centralized testing and established penetration of centralized testing supports the segment growth.
Senior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Point of Care Molecular Diagnostics Market is witnessing significant growth in the near future.
In 2023, the Assays & Kits segment accounted for noticeable share of global Point of Care Molecular Diagnostics Market and is projected to experience significant growth in the near future.
The PCR-based segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Abbott Laboratories Bayer Healthcare, Becton Dickinson and Company and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
By Product | Assays & Kits, Analyzers, Software & Services |
By Technology | PCR-based, Genetic Sequencing-based, Hybridization-based, Microarray-based |
By Application | Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, Other Applications |
By Test Location | OTC, POC |
By End-Use | Decentralized Labs, Hospitals, Homecare, Assisted Living Healthcare Facilities, Others |
List of Competitors | Abbott Laboratories Bayer Healthcare, F. Hoffmann La Roche AG, Becton Dickinson and Company, BioMerieux, Bio Rad Laboratories Inc., Cepheid Inc., Danaher Corporation, Johnson and Johnson |
This chapter will help you gain GLOBAL Market Analysis of Point of Care Molecular Diagnostics. Further deep in this chapter, you will be able to review Global Point of Care Molecular Diagnostics Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Point of Care Molecular Diagnostics. Further deep in this chapter, you will be able to review North America Point of Care Molecular Diagnostics Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Point of Care Molecular Diagnostics. Further deep in this chapter, you will be able to review Europe Point of Care Molecular Diagnostics Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Point of Care Molecular Diagnostics. Further deep in this chapter, you will be able to review Asia Pacific Point of Care Molecular Diagnostics Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Point of Care Molecular Diagnostics. Further deep in this chapter, you will be able to review South America Point of Care Molecular Diagnostics Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Point of Care Molecular Diagnostics. Further deep in this chapter, you will be able to review Middle East Point of Care Molecular Diagnostics Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Point of Care Molecular Diagnostics. Further deep in this chapter, you will be able to review Middle East Point of Care Molecular Diagnostics Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Point of Care Molecular Diagnostics. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation By Product Analysis 2019 -2031, will provide market size split by By Product. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by By Product Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by By Technology Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by By Application Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by By Test Location Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 14 Market Split by By End-Use Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Point of Care Molecular Diagnostics market
Chapter 15 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 16 Research Methodology and Sources
Why Assays & Kits have a significant impact on Point of Care Molecular Diagnostics market? |
What are the key factors affecting the Assays & Kits and Analyzers of Point of Care Molecular Diagnostics Market? |
What is the CAGR/Growth Rate of PCR-based during the forecast period? |
By type, which segment accounted for largest share of the global Point of Care Molecular Diagnostics Market? |
Which region is expected to dominate the global Point of Care Molecular Diagnostics Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|